Were using peptide therapy with semaglutide as one tool in the toolbox, and pairing it with holistic strategies for metabolic, hormonal, and whole body health
[10] Bloating is a highly subjective feeling of increased abdominal pressure
[PubMed: 12208249] 97
Wegovy commonly causes nausea (affecting up to 44% of users initially), whilst escitalopram may also produce nausea in approximately 1520% of patients, especially during the first few weeks of treatment
The differentiator is pathway-level insight mapping FTO, GLP1R, and MC4R variants the metabolic groundwork most GLP-1 telehealth programs, Hers and Ro included, do not address
Some individual providers may have exited the market or experienced supply delays, creating localized perception of discontinuation without representing industry-wide shutdown